CAJ 2.78% 37.0¢ capitol health limited

Ann: Presentation - Capitol's Offer for Integral Diagnostics, page-47

  1. 123 Posts.
    lightbulb Created with Sketch. 1
    Looking at CAJ and IDX's share price reaction over the last few days, I got  a feeling this takeover is not going to eventuate. By making a move for IDX, it had the potential to kill 3 birds with 1 stone.

    First Bird
    - IDX's share price would pounce post the announcement.
    - It created an opportunity to realise gains for some holders.

    Second Bird
    - CAJ's share price would slide post the announcement.
    - It created an opportunity to top up before the juicy half year report.

    Third Bird
    - The 11 x EBITDA price tag was a move to scare away other suitors.

    Disclaimer: All my personal opinion. Don't take it too seriously.
 
watchlist Created with Sketch. Add CAJ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.